MedPath

Evaluation of the effect of capsule of date palm pollen in infertile women with polycystic ovary syndrome

Phase 2
Completed
Conditions
Condition 1: Polycystic ovary syndrome. Condition 2: Infertility due to PCO.
Polycystic ovarian syndrome
Female infertility associated with anovulation
Registration Number
IRCT2017082016911N4
Lead Sponsor
Vice Chancellor for research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Clomiphene Citrate resistant infertile women with polycystic ovary syndrome
Exclusion criteria: Having no desire to cooperate; Having allergy to date palm pollen; Interrupt treatment in ovulation period; Not using Clomiphene or date palm pollen capsule; allergic to date palm pollen; having chronic disease(Heart, respiratory, kidney and digestive diseases); using other herbal drugs that affect infertility

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prolactine. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample.;Progestrone. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample.;Gonadotropines. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample.;Testestrone. Timepoint: Before and During intervention in Days 3 and 21 of cycle. Method of measurement: Blood Sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath